logo
  • Home
  • Programme
    • Excellence in Research
    • Excellence in Training
  • Consortium
  • Doctoral Candidates
    • DC1
    • DC2
    • DC3
    • DC4
    • DC5
    • DC6
    • DC7
    • DC8
    • DC9
    • DC10
  • Publications
  • Meetings
    • 1st Conference – Zaragoza
    • 2nd Conference – Porto

Consortium

Beneficiaries Partners

Coordinator

Università Degli Studi Di Firenze (UNIFI)

Italian flag Italy

Instituto De Investigação E Inovação Em Saúde Da Universidade Do Porto (i3s)

Portugal flag Portugal

Universidad De Zaragoza (UNIZAR)

Spain flag Spain

Danmarks Tekniske Universiteit (DTU)

Denmark flag Denmark

Centre National de la Recherche Scientifique (CNRS)

France flag France

Agencia Estatal Consejo Superior De Investigaciones Cientificas (CSIC)

Spain flag Spain

Univerza V Ljubljani (UL)

Slovenia flag Slovenia

Kobenhavns Universitet (UCPH)

Denmark flag Denmark

Associated Partners

GlyXera GmbH (GlyX)

German flag Germany

CiMaas (CiM)

Netherlands flag Netherlands

PAIA Biotech GmbH (PaiB)

German flag Germany

Carbohyde Zartkoruen Mukodo Reszvenytarsasag (CaH)

Hungary flag Hungary

Crelux GmbH (CreWu)

German flag Germany

Florida International University (FIU)

USA flag USA

Tuscan Organization of Universities and Research 4 Europe (TOUR4EU)

Belgium flag Belgium

Innovation Acta S.R.L. (InnoA)

Italian flag Italy

ComboTope Therapeutics

Denmark flag Denmark

Glycodisplay Aps (GD)

Denmark flag Denmark

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. This work has received funding from the European Union’s Horizon Europe research and innovation programme under the Marie Skłodowska-Curie Actions Grant Agreement n. 101119601 (GLYCANDRUG).

Newsletter

past newsletters

Do you want to receive the Glycandrugs news?

send us the request

Contact Us:

glycandrug@chim.unifi.it

Follow Us:

© 2025 GlycanDrug. Tutti i diritti riservati